Revvity Inc.
USUSDRevvity Inc. (LSE:0KHE) — Biotechnology: Laboratory Analytical Instruments. Anzahl der Börsen, an denen die Aktien des Unternehmens gehandelt werden: 3. Auf dieser Seite: Kurs und Chart, Dividenden, größte Aktionäre und Entwicklung der Aktienanzahl.
Über das Unternehmen
- Website
- revvity.com
- Sektor
- Industrials · Biotechnology: Laboratory Analytical Instruments
- Hauptsitz
- Waltham, United States
- CEO
- Prahlad R. Singh
- Mitarbeiter
- 11 000
- Ausstehende Aktien
- 111.59 Mio. Stand 2026-08-06
- Streubesitz
- 102.49 Mio.
- Marktkapitalisierung
- 16.63 Mrd. USD
- Insider
- 0.26%
- Institutionelle Anleger
- 96.55%
- Branche (SIC)
- Laboratory Analytical Instruments
- Rechtsform
- ZJTK
- LEI
- 549300IKL1SDPFI7N655
- Ausschüttungsquote
- 13.4%
- FCF
- 558 Mio. USD6%
- Schulden
- 3.21 Mrd. USD3.9 J. FCF
- Dividendenserie
- 43 J.
- Gewinn, FCF und gezahlte Dividenden — für die 12 Monate bis 05.07.2026 (letzter Bericht des Unternehmens).
Beschreibung
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Dividenden
Revvity Inc. (RVTY) zahlt vierteljährlich Dividenden. Pro Jahr (12 Monate bis einschließlich der zuletzt angekündigten Zahlung): 0.28 USD pro Aktie (Zahlungen: 4). Das entspricht etwa 0.18% des aktuellen Aktienkurses. Der nächste Ex-Dividenden-Tag ist der 23.10.2026: 0.07 USD pro Aktie, Zahlung am 13.11.2026. Ununterbrochene Dividendengeschichte: 43 Jahre.
| Ex-tag | Auszahlung | Betrag | % | Typ | Ticker |
|---|---|---|---|---|---|
| 2026-10-23 angekündigt | 2026-11-13 | 0.0700 USD | 0.0/0.2 % | vierteljährlich | US:RVTY |
| 2026-07-17 | 2026-08-07 | 0.0700 USD | 0.0/0.2 % | vierteljährlich | US:RVTY |
| 2026-04-17 | 2026-05-08 | 0.0700 USD | 0.0/0.2 % | vierteljährlich | US:RVTY |
| 2026-01-16 | 2026-02-06 | 0.0700 USD | 0.0/0.2 % | vierteljährlich | US:RVTY |
| 2025-10-17 | 2025-11-07 | 0.0700 USD | 0.0/0.2 % | vierteljährlich | US:RVTY |
| 2025-07-18 | 2025-08-08 | 0.0700 USD | 0.0/0.2 % | vierteljährlich | US:RVTY |
| 2025-04-17 | 2025-05-09 | 0.0700 USD | 0.0/0.2 % | vierteljährlich | US:RVTY |
| 2025-01-17 | 2025-02-07 | 0.0700 USD | 0.0/≈0.2 % | vierteljährlich | US:RVTY |
| 2024-10-18 | 2024-11-08 | 0.0700 USD | 0.0/≈0.2 % | vierteljährlich | US:RVTY |
| 2024-07-19 | 2024-08-09 | 0.0700 USD | 0.0/≈0.2 % | vierteljährlich | US:RVTY |
Neuigkeiten Diese Woche
Pressemitteilungen von der Investoren-Website des Unternehmens, täglich aktualisiert. Links führen zur Website des Unternehmens. Die Schlagzeilen sind in der Originalsprache, wie auf der Firmenwebsite.
| 06.10.2026 | Revvity to Host Investor Day |
Größte Anteilseigner
| Inhaber | Anteil | Aktien | Berichtsdatum |
|---|---|---|---|
| T. Rowe Price Investment… | 16.37% | 18.26 Mio. | 2026-06-30 |
| T. ROWE PRICE CAPITAL AP… | 10.2% | 11.38 Mio. | 2026-06-30 |
| Jupiter Topco LLC | 7.74% | 8.64 Mio. | 2026-06-30 |
| Edgepoint Investment Gro… | 7.66% | 8.54 Mio. | 2026-06-30 |
| Blackrock Inc. | 6.86% | 7.66 Mio. | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 7.3 Mio. | 2026-06-30 |
| JANUS INVESTMENT FUND-Ja… | 5.15% | 5.75 Mio. | 2026-06-30 |
| Price (T.Rowe) Associate… | 4.96% | 5.53 Mio. | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.28% | 4.77 Mio. | 2026-06-30 |
| State Street Corporation | 3.89% | 4.34 Mio. | 2026-06-30 |
| Victory Capital Manageme… | 3.27% | 3.65 Mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 3.55 Mio. | 2026-06-30 |
| Dimensional Fund Advisor… | 3.07% | 3.43 Mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 2.89 Mio. | 2026-06-30 |
| -Price (T.Rowe) U.S. Val… | 2.41% | 2.69 Mio. | 2026-06-30 |
| TR PRICE-Price (T.Rowe)… | 2.41% | 2.69 Mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.29% | 2.56 Mio. | 2026-06-30 |
| JNL Series Trust-JNL/T.… | 2.27% | 2.53 Mio. | 2026-06-30 |
| Victory Portfolios-Victo… | 2.12% | 2.37 Mio. | 2026-06-30 |
| T. Rowe Price Value Fund… | 1.93% | 2.16 Mio. | 2026-06-30 |
| Invesco Exchange-Traded… | 1.67% | 1.87 Mio. | 2026-08-31 |
| SINGH PRAHLAD R (Chief E… | ≈0.09% | 105 676 | 2026-08-13 |
| GOLDBERG JOEL S (General… | ≈0.09% | 105 223 | 2026-08-14 |
| BARRETT PETER (Director) | ≈0.03% | 28 293 | 2026-05-07 |
| WITNEY FRANKLIN R. PH.D.… | ≈0.02% | 23 354 | 2026-05-07 |
| CHAPIN SAMUEL R. (Direct… | ≈0.02% | 22 676 | 2026-05-07 |
| VICTOR MIRIAME (Officer) | ≈0.02% | 18 122 | 2026-02-24 |
| WITZ PASCALE (Director) | ≈0.01% | 15 985 | 2026-05-07 |
| KRAKOWIAK MAXWELL (Chief… | ≈0.01% | 14 781 | 2026-09-21 |
| MICHAS ALEXANDROS P (Dir… | — | — | 2026-08-25 |
| MICHAS ALEXIS P (Directo… | — | — | 2025-08-27 |
